In preclinical work, GLP-2-TZ was designed to switch on two incretin receptors at once — the GIP and GLP-1 receptors — the first dual-incretin approach to reach late-stage study.
GIP + GLP-1 engaged
Dual-incretin agonist mechanism
Search peptides — top sellers first
Search peptides — top sellers first
Search peptides — top sellers first
Dual-incretin-receptor research peptide, supplied for laboratory research use only.
$139/ 30mg vial
$69.50 per vial with Buy 1, Get 1 Free
All products currently listed on this site are for research purposes only.
Frequently bought together
Related supplies, one order, one delivery.

Reconstitution Solution · 10ml
Popular

GHK-CU · 50mg

Melanotan 2 · 10mg
Most sellers show one certificate and hope you never ask again. We publish a signed report for every batch we release, tied to the lot number on your vial. Purity is an exact number, not a “passes.” If a batch fails, it never ships.

A dual-incretin research peptide studied for hitting two metabolic receptors in parallel.
Glucagon-like peptide-1 signalling is studied for glucose-dependent insulin release and appetite regulation.
Glucose-dependent insulinotropic polypeptide is investigated for insulin sensitivity and nutrient handling.
The paired receptor action is researched for combined effects on blood sugar, lipids and body weight.
For research use only. Mechanisms described reflect published research literature.
Anyone can show you one good report. Here is every batch of GLP-2-TZ we have ever released, newest first, each with its own signed report. Nothing hidden, nothing cherry-picked.
Published findings on this compound, each linked to its source. Animal and lab results are context, not claims about this product.
In preclinical work, GLP-2-TZ was designed to switch on two incretin receptors at once — the GIP and GLP-1 receptors — the first dual-incretin approach to reach late-stage study.
GIP + GLP-1 engaged
Dual-incretin agonist mechanism
Across late-stage clinical research, HbA1c — the standard long-term blood-sugar marker — fell relative to baseline, though a fixed magnitude was not established here.
Directional reduction; exact magnitude not fixed
In metabolic research cohorts, lipid markers shifted in a favorable direction versus baseline, pointing to a broader metabolic effect.
Directional improvement; magnitude not quantified
Quick answers about GLP-2-TZ.
Test any batch at any lab you like. If it doesn't match our report, you get every dollar back. No return shipping, no forms, no arguments.